about
Oriented immobilized anti-hIgG via F(c) fragment-imprinted PHEMA cryogel for IgG purification.Development of high-productivity, strong cation-exchange adsorbers for protein capture by graft polymerization from membranes with different pore sizes.Isolation and characterization of chimeric human Fc-expressing proteins using protein a membrane adsorbers and a streamlined workflow.Application of monoliths for bioparticle isolation.Functional monolithic platforms: chromatographic tools for antibody purification.Challenges and recent advances in affinity purification of tag-free proteins.Downstream Processing Technologies/Capturing and Final Purification : Opportunities for Innovation, Change, and Improvement. A Review of Downstream Processing Developments in Protein Purification.Sophisticated Cloning, Fermentation, and Purification Technologies for an Enhanced Therapeutic Protein Production: A Review.Ultrafiltration behavior of monoclonal antibodies and Fc-fusion proteins: Effects of physical properties.Continuous counter-current chromatography for capture and polishing steps in biopharmaceutical production.Affinity-based precipitation via a bivalent peptidic hapten for the purification of monoclonal antibodies.Scale-Up of Protein Purification: Downstream Processing Issues.Continuous Manufacturing of Recombinant Therapeutic Proteins: Upstream and Downstream Technologies.Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture.Production of Erythropoietin-Specific Polyclonal Antibodies.Development of robust antibody purification by optimizing protein-A chromatography in combination with precipitation methodologies.Development of a novel and efficient cell culture flocculation process using a stimulus responsive polymer to streamline antibody purification processesPurification of monoclonal antibodies by hydrophobic interaction chromatography under no-salt conditions.Use of biotinylated ubiquitin for analysis of rat brain mitochondrial proteome and interactome.Automated sample preparation for CE-SDS.Monoclonal Antibodies Production Platforms: An Opportunity Study of a Non-Protein-A Chromatographic Platform Based on Process Economics.Trends in Upstream and Downstream Process Development for Antibody Manufacturing.A megaporous material harbouring a peptide ligand for affinity IgG purification.Highly efficient and easy protease-mediated protein purification.High throughput screening of particle conditioning operations: I. System design and method development.Application of calcium phosphate flocculation in high-density cell culture fluid with high product titer of monoclonal antibody.A fine-tuned composition of protein nanofibrils yields an upgraded functionality of displayed antibody binding domains.Advective hydrogel membrane chromatography for monoclonal antibody purification in bioprocessing.A comparison of protein A chromatographic stationary phases: performance characteristics for monoclonal antibody purification.Molecular recognition of Fc-specific ligands binding onto the consensus binding site of IgG: insights from molecular simulation.Membrane-based hydrophobic interaction chromatography
P2860
Q34446506-91633E6F-EDD2-47B5-A246-DA3BB8627576Q34486515-AD4B91A7-F716-4154-BD8D-28BCD33CE822Q37489561-E87CB097-B231-4C41-A2C6-CFD5A13EDC86Q38056666-D33EB703-0657-4EFF-8D3A-309052BE2F89Q38104707-2832282B-7B0B-46E3-A989-AE686D14F4E9Q38198528-E022145B-D3D4-449A-BE7C-8967AC7D5AEDQ38631194-1BACA257-7747-4E62-8D8B-94370BB88695Q38654852-72C327E1-48C6-4D15-9E48-7910DB1C1502Q38808721-D44461E7-D4AA-4760-8218-D5CF72C39E3AQ38845449-1A752698-0A6F-43A0-B066-C671E61A8B59Q38976980-0DED8735-4C61-4E88-AB43-8D2C99D92CA4Q38978537-F4ACE191-00BF-417C-907E-0498C62EEF2CQ39164854-C275A966-FF50-4144-BD8B-D2CEB7C74E95Q41551902-F4572823-BF48-4CA5-AF20-CAFAA18F12A0Q41674015-B75F723C-BAA8-46F6-B9C2-A47BD216D0E0Q41756218-92C2A5CE-A67F-418A-AB3D-95D8C77BF692Q41889129-2B599494-1ABD-4FDD-882B-9DEAAF683475Q41963869-D30F10F6-CEA6-4226-A7F0-B699976C20FCQ42133439-A82AC0C0-13FC-4C55-9041-902E67BFB31CQ44202803-F3ADF170-7E8F-40A4-9BB1-FA155151EBBAQ47321273-700E18A5-7115-44F4-94D7-A2EAFF8B0CCDQ47843398-7DEE1336-CEDD-4ED5-AF11-1D437BE62F9DQ47916624-92DF9DC7-9935-4FED-9F0E-E30372A5FD7DQ50237169-726F0083-A80B-4581-A759-52B7A7E400C8Q50598305-1B25B4A0-93CC-472C-AC14-30B5965253A4Q50881776-68ACD63B-44B3-48C1-A78A-5DA831E6929FQ51074523-A8043D76-8B67-4FE6-8547-59183A32A9DBQ51742818-CFB45B5A-D2A6-4F2C-A77B-903999FECEB9Q51748764-02895094-C9EB-4CB6-B3D6-D4974B0E3E0FQ53512112-92CFA77B-6A4E-4973-AEF9-297D5C2C8295Q57369262-A588ECB6-CAEC-4F3B-AE54-64BB9E9A2B8A
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Technology trends in antibody purification.
@en
Technology trends in antibody purification.
@nl
type
label
Technology trends in antibody purification.
@en
Technology trends in antibody purification.
@nl
prefLabel
Technology trends in antibody purification.
@en
Technology trends in antibody purification.
@nl
P1476
Technology trends in antibody purification.
@en
P2093
Pete Gagnon
P356
10.1016/J.CHROMA.2011.10.034
P407
P577
2011-10-20T00:00:00Z